Kara Elam is currently working on her Doctorate in Health Policy. She holds Master Degrees in both epidemiology and microbiology. Her research interests include emerging viral diseases, the intersection of human rights and intellectual property rights, and ending violence against women.
The U.S. Food and Drug Administration (FDA) approved Genentech’s Avastin in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer (psOC). This marks the first new psOC treatment option ... Read more
Researchers at Cold Spring Harbor Laboratory (CSHL) published findings that highlight the discovery of a new cancer signaling pathway that may prove useful in the efforts to prevent metastasis in ovarian cancer (OC). ... Read more
A recently published study shows that a system-wide educational program for healthcare providers about the potential of salpingectomy to reduce ovarian cancer risk resulted in a significant increase in the number ... Read more
UK researchers have recently suggested that the current guidelines for women to receive risk-reducing salpingo-oophorectomy (RRSO) should be re-evaluated in order to allow the cost-effective and lifesaving procedure for women with as little ... Read more